Mitsuo Satoh
About
Mitsuo Satoh is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Materials Chemistry.
According to data from OpenAlex, Mitsuo Satoh has authored 88 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 30 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Materials Chemistry. Recurrent topics in Mitsuo Satoh's work include Monoclonal and Polyclonal Antibodies Research (29 papers), Glycosylation and Glycoproteins Research (25 papers) and Solid-state spectroscopy and crystallography (23 papers). Mitsuo Satoh is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (29 papers), Glycosylation and Glycoproteins Research (25 papers) and Solid-state spectroscopy and crystallography (23 papers). Mitsuo Satoh collaborates with scholars based in Japan, Singapore and United States. Mitsuo Satoh's co-authors include Kenya Shitara, Shigeru Iida, Rinpei Niwa, Kazuhisa Uchida, Yutaka Kanda, Naoko Yamane‐Ohnuki, Masako Wakitani, Nobuo Hanai, Motoo Yamasaki and Toyohide Shinkawa and has published in prestigious journals such as Journal of Biological Chemistry, Physical review. B, Condensed matter and PLoS ONE.
In The Last Decade
Mitsuo Satoh
84 papers receiving 4.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mitsuo Satoh Japan | 29 | 3.8k | 3.4k | 1.8k | 690 | 476 | 88 | 5.1k | ||
| Paul J. Carter United States | 22 | 2.9k 0.8× | 2.8k 0.8× | 1.2k 0.6× | 1.3k 1.9× | 225 0.5× | 42 | 4.8k | ||
| Lutz Riechmann United Kingdom | 22 | 2.3k 0.6× | 2.1k 0.6× | 851 0.5× | 506 0.7× | 228 0.5× | 34 | 3.5k | ||
| K E Hellström United States | 47 | 3.0k 0.8× | 3.1k 0.9× | 3.1k 1.7× | 2.0k 3.0× | 446 0.9× | 106 | 7.1k | ||
| Thomas Garrett Australia | 29 | 2.7k 0.7× | 1.8k 0.5× | 1.5k 0.9× | 1.8k 2.6× | 209 0.4× | 49 | 5.4k | ||
| Greg A. Lazar United States | 24 | 2.1k 0.6× | 2.2k 0.6× | 1.2k 0.6× | 755 1.1× | 201 0.4× | 44 | 3.5k | ||
| David Colcher United States | 55 | 3.9k 1.0× | 6.7k 1.9× | 1.9k 1.0× | 3.2k 4.6× | 462 1.0× | 208 | 9.9k | ||
| Tony Lahoutte Belgium | 50 | 3.1k 0.8× | 4.5k 1.3× | 1.3k 0.7× | 2.1k 3.0× | 222 0.5× | 163 | 7.3k | ||
| Jefferson Foote United States | 21 | 2.1k 0.5× | 2.1k 0.6× | 875 0.5× | 439 0.6× | 211 0.4× | 30 | 3.3k | ||
| Nick Devoogdt Belgium | 51 | 3.3k 0.9× | 5.1k 1.5× | 2.1k 1.2× | 2.7k 4.0× | 278 0.6× | 155 | 8.2k | ||
| Rob C. Roovers Netherlands | 32 | 2.6k 0.7× | 2.5k 0.7× | 1.1k 0.6× | 1.0k 1.5× | 206 0.4× | 49 | 4.2k |
Countries citing papers authored by Mitsuo Satoh
Since
Specialization
Citations
This map shows the geographic impact of Mitsuo Satoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuo Satoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuo Satoh more than expected).
Fields of papers citing papers by Mitsuo Satoh
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mitsuo Satoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuo Satoh. The network helps show where Mitsuo Satoh may publish in the future.
Co-authorship network of co-authors of Mitsuo Satoh
This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuo Satoh. A scholar is included among the top collaborators of Mitsuo Satoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuo Satoh. Mitsuo Satoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Yanagibashi, Tsutomu, Mitsuo Satoh, Yoshinori Nagai, Masamichi Koike, & Kiyoshi Takatsu. (2017). Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5. Cytokine. 98. 59–70.
2.
Yamada, Tsuyoshi, Yutaka Kanda, Makoto Takayama, et al.. (2016). Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides. Glycobiology. 26(5). 482–492.
3.
Niwa, Rinpei & Mitsuo Satoh. (2015). The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology. Journal of Pharmaceutical Sciences. 104(3). 930–941.
4.
Mizushima, Tsunehiro, Hirokazu Yagi, Shigeru Iida, et al.. (2011). Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes to Cells. 16(11). 1071–1080.
5.
Yamane‐Ohnuki, Naoko & Mitsuo Satoh. (2009). Production of therapeutic antibodies with controlled fucosylation. mAbs. 1(3). 230–236.
6.
Kubota, Tsuguo, Rinpei Niwa, Mitsuo Satoh, et al.. (2009). Engineered therapeutic antibodies with improved effector functions. Cancer Science. 100(9). 1566–1572.
7.
Yamane‐Ohnuki, Naoko, Kazuya Yamano, & Mitsuo Satoh. (2008). Biallelic Gene Knockouts in Chinese Hamster Ovary Cells. Methods in molecular biology. 435. 1–16.
8.
Iida, S., Akira Okazaki, Keisuke Mori, et al.. (2008). The N-linked oligosaccharide at Fc RIIIa Asn-45: an inhibitory element for high Fc RIIIa binding affinity to IgG glycoforms lacking core fucosylation. Glycobiology. 19(2). 126–134.
9.
Matsumiya, S., Yoshiki Yamaguchi, Junichi Saito, et al.. (2007). Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1. Journal of Molecular Biology. 368(3). 767–779.
10.
Mori, Katsuhiro, Miho Inoue, Masako Wakitani, et al.. (2007). Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC. BMC Biotechnology. 7(1). 84–84.
11.
Iida, Shigeru, Hirofumi Misaka, Miho Inoue, et al.. (2006). Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa. Clinical Cancer Research. 12(9). 2879–2887.
12.
Satoh, Mitsuo, Kenya Shitara, & Nobuo Hanai. (2006). The Current Stream and Prospect of Glycoscience Application-Therapeutic Antibodies-. Trends in Glycoscience and Glycotechnology. 18(100). 129–136.
13.
Natsume, Akito, Masako Wakitani, Naoko Yamane‐Ohnuki, et al.. (2006). Fucose Removal from Complex-Type Oligosaccharide Enhances the Antibody-Dependent Cellular Cytotoxicity of Single-Gene–Encoded Bispecific Antibody Comprising of Two Single-Chain Antibodies Linked to the Antibody Constant Region. The Journal of Biochemistry. 140(3). 359–368.
14.
Yamano, Kazuya, et al.. (2005). Human adenosine A3 receptor leads to intracellular Ca2+ mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase γ in mice. Biochemical Pharmacology. 70(10). 1487–1496.
15.
Niwa, Rinpei, Akito Natsume, Masako Wakitani, et al.. (2005). IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. Journal of Immunological Methods. 306(1-2). 151–160.
16.
Yamane‐Ohnuki, Naoko, Satoko Kinoshita, Shigeru Iida, et al.. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity. Biotechnology and Bioengineering. 87(5). 614–622.
17.
Shinkawa, Toyohide, Kazuyasu Nakamura, Yutaka Kanda, et al.. (2003). The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity. Journal of Biological Chemistry. 278(5). 3466–3473.
18.
Satoh, Mitsuo, et al.. (1993). Stable production of recombinant pro-urokinase by human lymphoblastoid Namalwa KJM-1 cells: Host-cell dependency of the expressed-protein stability. Cytotechnology. 13(2). 79–88.
19.
Yokosawa, Hideyoshi, et al.. (1989). Involvement of Angiotensin-Converting Enzyme (Kininase II) in Neuropeptide Metabolism. Advances in experimental medicine and biology. 247B. 371–376.
20.
Kanashiro, Tatsuo, Takashi Ohno, & Mitsuo Satoh. (1983). Orientation Dependence of the Quadrupole Relaxation in NaNO2. Japanese Journal of Applied Physics. 22(4A). L253–L253.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paul J. Carter Breakdown of academic impact, for papers by Lutz Riechmann Breakdown of academic impact, for papers by K E Hellström Breakdown of academic impact, for papers by Thomas Garrett Breakdown of academic impact, for papers by Greg A. Lazar Breakdown of academic impact, for papers by David Colcher Breakdown of academic impact, for papers by Tony Lahoutte Breakdown of academic impact, for papers by Jefferson Foote Breakdown of academic impact, for papers by Nick Devoogdt Breakdown of academic impact, for papers by Rob C. Roovers